Determining the natural history of pancreatic cystic neoplasms: a Manitoban cohort study
- PMID: 27037209
- PMCID: PMC4814595
- DOI: 10.1016/j.hpb.2015.11.001
Determining the natural history of pancreatic cystic neoplasms: a Manitoban cohort study
Abstract
Background: Most pancreatic cystic neoplasms (PCN) are thought to harbor a low malignant potential. This historical cohort study attempts to describe the natural history of these lesions in a provincial cohort, to assess the safety of non-surgical management. Pathological diagnosis of malignancy was the primary outcome measure of interest.
Methods: All adult patients (age 18+) with PCN seen between 2000 and 2012 by the two main institutions in Manitoba were included in this study. PCN were graded as high and low risk, which dictated initial treatment plan (surgery or observation). Predictors of initial surgical treatment, delayed surgery in the observation group and the clinical/radiological predictors of malignancy were determined.
Results: 497 patients were included in this study. 43 (8.7%) high-risk lesions underwent initial surgery, with 13 (30.2%) cases of malignancy discovered. 450 (90.5%) low-risk cysts were observed for a median of 17.3 months (range: 0.00-142.3). 29 (6.4%) cases of delayed surgery occurred, with malignancy discovered in five (17.2%).
Conclusions: This study supports current selection criteria for management of PCNs. Due to the low incidence of malignancy in low-risk PCN, it appears that long-term observation is safe and should be the treatment modality of choice in the absence of high-risk features.
Copyright © 2016 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
International guidelines for the management of pancreatic intraductal papillary mucinous neoplasms.World J Gastroenterol. 2015 Sep 14;21(34):9833-7. doi: 10.3748/wjg.v21.i34.9833. World J Gastroenterol. 2015. PMID: 26379390 Free PMC article.
-
Management of the rare entity of primary pancreatic cystic neoplasms.J Gastroenterol Hepatol. 2009 Jul;24(7):1203-10. doi: 10.1111/j.1440-1746.2009.05855.x. Epub 2009 May 10. J Gastroenterol Hepatol. 2009. PMID: 19467142 Review.
-
Natural history of asymptomatic pancreatic cystic neoplasms.HPB (Oxford). 2013 Mar;15(3):175-81. doi: 10.1111/j.1477-2574.2012.00522.x. Epub 2012 Jul 23. HPB (Oxford). 2013. PMID: 23374357 Free PMC article.
-
Pancreatic cystic neoplasms: management and unanswered questions.Gastroenterology. 2013 Jun;144(6):1303-15. doi: 10.1053/j.gastro.2013.01.073. Gastroenterology. 2013. PMID: 23622140 Review.
-
Prediction of malignancy in cystic neoplasms of the pancreas: a population-based cohort study.Am J Gastroenterol. 2014 Jan;109(1):121-9; quiz 130. doi: 10.1038/ajg.2013.334. Epub 2013 Oct 1. Am J Gastroenterol. 2014. PMID: 24080609
Cited by
-
Glycopatterns and Glycoproteins Changes in MCN and SCN: A Prospective Cohort Study.Biomed Res Int. 2019 Jul 31;2019:2871289. doi: 10.1155/2019/2871289. eCollection 2019. Biomed Res Int. 2019. PMID: 31467879 Free PMC article.
-
Optimal Follow-up of Incidental Pancreatic Cystic Lesions without Worrisome Features: Clinical Outcome after Long-term Follow-up.Gut Liver. 2024 Mar 15;18(2):328-337. doi: 10.5009/gnl230017. Epub 2023 Oct 10. Gut Liver. 2024. PMID: 37840221 Free PMC article.
References
-
- Ohashi K., Murakami Y., Mardyama M. Four cases of “mucin producing” cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc. 1982;20:348–351.
-
- Schmidt C.M., White P.B., Waters J.A., Yiannoutsos C.T., Cummings O.W., Baker M. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007;246:644–651. discussion 651–4. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical